Company page

Eyepoint, Inc.

Eyepoint, Inc. is a public company traded under the ticker EYPT in the American market. The company has a market capitalization of approximately $1.02 billion. Eyepoint focuses on developing innovative therapeutics for eye diseases, aiming to improve patient outcomes through advanced drug delivery systems.

EYPT:NASDAQUpdated August 28, 2026
Eyepoint, Inc. logo
Ticker
EYPT:NASDAQ
Asset type
Stock
Market cap
$386.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD